Insmed Price Target Cut to $207 From $237 by Barclays
Barclays cut its price target on Insmed to $207.00 per share from $237.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.